{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "c3d3b71f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from datasets import Dataset\n",
    "import os\n",
    "from transformers import AutoTokenizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "acd9a67d",
   "metadata": {},
   "outputs": [],
   "source": [
    "PROCESSED_DATA_FOLDER = os.path.join(\"../data\", \"processed\")\n",
    "ANNOTATION_FILE = os.path.join(PROCESSED_DATA_FOLDER, \"all.json\")\n",
    "OUTPUT_DATASET_FOLDER = os.path.join(\"../data\", \"ner_dataset\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "e84f8c62",
   "metadata": {},
   "outputs": [],
   "source": [
    "MODEL_CHECKPOINT = \"dmis-lab/biobert-base-cased-v1.1\"\n",
    "LABELS = [\"CONDITION\", \"DRUG\", \"LAB_TEST\", \"VALUE\", \"OPERATOR\", \"PROCEDURE\", \"DEMOGRAPHIC\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "cc19c8f9",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(ANNOTATION_FILE, 'r', encoding='utf-8') as f:\n",
    "    raw_data = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "7d7016b0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'University students at school',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'University students'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Smoking (≥1 cigarette/week);',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '1 cigarette/week'}]},\n",
       " {'text': 'heavy alcohol consumption (>224 g/week for men and >168 g/week for women);',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'men'},\n",
       "   {'label': 'demographic', 'entity': 'women'},\n",
       "   {'label': 'operator', 'entity': '>'},\n",
       "   {'label': 'value', 'entity': '224 g/week'},\n",
       "   {'label': 'operator', 'entity': '>'},\n",
       "   {'label': 'value', 'entity': '168 g/week'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '≥18years old',\n",
       "  'entities': [{'label': 'demographic', 'entity': '≥18years old'}]},\n",
       " {'text': 'Histopathologically confirmed FIGO II-IV stage primary ovarian cancer peritoneal or fallopian tube cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'ovarian cancer'},\n",
       "   {'label': 'condition', 'entity': 'peritoneal'},\n",
       "   {'label': 'condition', 'entity': 'fallopian tube cancer'}]},\n",
       " {'text': 'Patients who underwent primary tumor reduction or intermediate tumor reduction with satisfactory results (R0/R1) within 15 days after surgery',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'primary tumor reduction'},\n",
       "   {'label': 'procedure', 'entity': 'intermediate tumor reduction'},\n",
       "   {'label': 'procedure', 'entity': 'surgery'}]},\n",
       " {'text': 'After tumor reduction, the physician assessed that chemotherapy was not suitable or the patient was unwilling to receive chemotherapy',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'tumor reduction'},\n",
       "   {'label': 'procedure', 'entity': 'chemotherapy'}]},\n",
       " {'text': 'Life expectancy is 3 months',\n",
       "  'entities': [{'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': 'Liver and kidney function :', 'entities': []},\n",
       " {'text': 'AST and ALT 3 times the upper limit of normal value or 5 times the upper limit of normal value in the presence of liver metastasis; T',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'AST'},\n",
       "   {'label': 'lab_test', 'entity': 'ALT'},\n",
       "   {'label': 'value', 'entity': '3 times the upper limit of normal'},\n",
       "   {'label': 'value', 'entity': '5 times the upper limit of normal'},\n",
       "   {'label': 'condition', 'entity': 'liver metastasis'}]},\n",
       " {'text': 'he upper limit of total bilirubin 3 times normal value;',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'total bilirubin'},\n",
       "   {'label': 'value', 'entity': '3 times normal value'}]},\n",
       " {'text': 'Serum creatinine is 3 times the upper limit of normal',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Serum creatinine'},\n",
       "   {'label': 'value', 'entity': '3 times the upper limit of normal'}]},\n",
       " {'text': 'No other tumors, no history of other malignant tumors (except non-melanoma skin cancer in situ cervical cancer or other cancers that have received curative treatment and have no signs of disease for at least 5 years)',\n",
       "  'entities': [{'label': 'condition', 'entity': 'tumors'},\n",
       "   {'label': 'condition', 'entity': 'malignant tumors'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'},\n",
       "   {'label': 'condition', 'entity': 'cancers'},\n",
       "   {'label': 'procedure', 'entity': 'curative treatment'},\n",
       "   {'label': 'value', 'entity': 'at least 5 years'}]},\n",
       " {'text': 'Voluntarily participate in the study and sign the informed consent',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Breastfeeding women during pregnancy',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Breastfeeding women'},\n",
       "   {'label': 'demographic', 'entity': 'pregnancy'}]},\n",
       " {'text': 'Recurrent ovarian cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Recurrent ovarian cancer'}]},\n",
       " {'text': 'Known allergy to the study drug;',\n",
       "  'entities': [{'label': 'drug', 'entity': 'study drug'}]},\n",
       " {'text': 'Central nervous system diseases or brain metastases;',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Central nervous system diseases'},\n",
       "   {'label': 'condition', 'entity': 'brain metastases'}]},\n",
       " {'text': 'History of abdominal/pelvic radiotherapy;',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'radiotherapy'}]},\n",
       " {'text': 'History of organ transplantation history of immune deficiency disease requiring systemic steroid therapy',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'organ transplantation'},\n",
       "   {'label': 'condition', 'entity': 'immune deficiency disease'},\n",
       "   {'label': 'drug', 'entity': 'steroid'}]},\n",
       " {'text': 'severe uncontrolled hypertension, uncontrolled diabetes mellitus, and clinically significant cardiovascular and cerebrovascular diseases;',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled hypertension'},\n",
       "   {'label': 'condition', 'entity': 'uncontrolled diabetes mellitus'},\n",
       "   {'label': 'condition',\n",
       "    'entity': 'cardiovascular and cerebrovascular diseases'}]},\n",
       " {'text': 'History of other malignant tumors within 5 years (except for cured skin basal cell carcinoma and cervical carcinoma in situ);',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignant tumors'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'skin basal cell carcinoma'},\n",
       "   {'label': 'condition', 'entity': 'cervical carcinoma in situ'}]},\n",
       " {'text': 'Any other factors that the investigator believes are not appropriate for participation in the study.',\n",
       "  'entities': []},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'Sleep complaints and a score of >5 on the Pittsburgh Sleep Quality Index',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Sleep complaints'},\n",
       "   {'label': 'lab_test', 'entity': 'Pittsburgh Sleep Quality Index'},\n",
       "   {'label': 'operator', 'entity': '>'},\n",
       "   {'label': 'value', 'entity': '5'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Any medical condition that could contribute to sleep problems (e.g., pain, respiratory problems, hyperthyroidism)',\n",
       "  'entities': [{'label': 'condition', 'entity': 'medical condition'},\n",
       "   {'label': 'condition', 'entity': 'sleep problems'},\n",
       "   {'label': 'condition', 'entity': 'pain'},\n",
       "   {'label': 'condition', 'entity': 'respiratory problems'},\n",
       "   {'label': 'condition', 'entity': 'hyperthyroidism'}]},\n",
       " {'text': 'Use of medications that could affect sleep (e.g., stimulants, sedatives)',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'},\n",
       "   {'label': 'drug', 'entity': 'stimulants'},\n",
       "   {'label': 'drug', 'entity': 'sedatives'}]},\n",
       " {'text': 'A diagnosis of a sleep disorder other than insomnia (e.g., obstructive sleep apnea)',\n",
       "  'entities': [{'label': 'condition', 'entity': 'sleep disorder'},\n",
       "   {'label': 'condition', 'entity': 'insomnia'},\n",
       "   {'label': 'condition', 'entity': 'obstructive sleep apnea'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'Diagnosis of moderate to severe chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': 'At least 20 natural teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': 'Probing depth of ≥5 mm in at least four sites',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Systemic conditions that could affect periodontal health (e.g., diabetes, immunosuppression)',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic conditions'},\n",
       "   {'label': 'condition', 'entity': 'diabetes'},\n",
       "   {'label': 'condition', 'entity': 'immunosuppression'}]},\n",
       " {'text': 'Use of medications that could affect periodontal health (e.g., phenytoin, cyclosporine)',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'},\n",
       "   {'label': 'drug', 'entity': 'phenytoin'},\n",
       "   {'label': 'drug', 'entity': 'cyclosporine'}]},\n",
       " {'text': 'Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': 'Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': 'History of periodontal surgery in the preceding 12 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'periodontal surgery'},\n",
       "   {'label': 'value', 'entity': '12 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'Histologically confirmed invasive carcinoma of the breast',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'invasive carcinoma of the breast'}]},\n",
       " {'text': 'HER2-positive tumor',\n",
       "  'entities': [{'label': 'condition', 'entity': 'HER2-positive tumor'}]},\n",
       " {'text': 'Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Metastatic disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Metastatic disease'}]},\n",
       " {'text': 'Prior treatment with Herceptin (trastuzumab) or other HER2-targeted therapy',\n",
       "  'entities': [{'label': 'drug', 'entity': 'Herceptin'},\n",
       "   {'label': 'drug', 'entity': 'trastuzumab'},\n",
       "   {'label': 'drug', 'entity': 'HER2-targeted therapy'}]},\n",
       " {'text': 'History of other malignancy within the past 5 years',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': \"A clinical diagnosis of Huntington's disease (HD) confirmed by genetic testing\",\n",
       "  'entities': [{'label': 'condition', 'entity': \"Huntington's disease (HD)\"},\n",
       "   {'label': 'procedure', 'entity': 'genetic testing'}]},\n",
       " {'text': \"A score of ≥5 on the Unified Huntington's Disease Rating Scale (UHDRS) motor subscale\",\n",
       "  'entities': [{'label': 'lab_test',\n",
       "    'entity': \"Unified Huntington's Disease Rating Scale (UHDRS) motor subscale\"},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5'}]},\n",
       " {'text': 'A score of ≥2 on the UHDRS cognitive subscale',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'UHDRS cognitive subscale'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '2'}]},\n",
       " {'text': 'A score of ≥2 on the UHDRS functional subscale',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'UHDRS functional subscale'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '2'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Any other neurological or psychiatric condition that could interfere with the assessment of HD symptoms',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'neurological or psychiatric condition'},\n",
       "   {'label': 'condition', 'entity': 'HD symptoms'}]},\n",
       " {'text': 'Use of any medication that could interfere with the assessment of HD symptoms',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medication'},\n",
       "   {'label': 'condition', 'entity': 'HD symptoms'}]},\n",
       " {'text': 'A history of substance abuse or dependence',\n",
       "  'entities': [{'label': 'condition', 'entity': 'substance abuse'},\n",
       "   {'label': 'condition', 'entity': 'dependence'}]},\n",
       " {'text': 'Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'Adult patients (≥18 years of age) with a diagnosis of ARDS according to the Berlin definition.',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Adult patients'},\n",
       "   {'label': 'demographic', 'entity': '≥18 years of age'},\n",
       "   {'label': 'condition', 'entity': 'ARDS'}]},\n",
       " {'text': 'PaO2/FiO2 ratio < 200 mmHg with a PEEP ≥ 5 cmH2O.',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'PaO2/FiO2 ratio'},\n",
       "   {'label': 'lab_test', 'entity': 'PEEP'},\n",
       "   {'label': 'operator', 'entity': '<'},\n",
       "   {'label': 'value', 'entity': '200 mmHg'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 cmH2O'}]},\n",
       " {'text': 'Bilateral opacities on chest radiograph or CT scan not fully explained by effusions, lobar/lung collapse, or nodules.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Bilateral opacities'},\n",
       "   {'label': 'procedure', 'entity': 'chest radiograph'},\n",
       "   {'label': 'procedure', 'entity': 'CT scan'},\n",
       "   {'label': 'condition', 'entity': 'effusions'},\n",
       "   {'label': 'condition', 'entity': 'lobar/lung collapse'},\n",
       "   {'label': 'condition', 'entity': 'nodules'}]},\n",
       " {'text': 'Respiratory failure not fully explained by cardiac failure or fluid overload.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Respiratory failure'},\n",
       "   {'label': 'condition', 'entity': 'cardiac failure'},\n",
       "   {'label': 'condition', 'entity': 'fluid overload'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Pregnancy.',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'}]},\n",
       " {'text': 'Morbid obesity (body mass index > 40 kg/m2).',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Morbid obesity'},\n",
       "   {'label': 'lab_test', 'entity': 'body mass index'},\n",
       "   {'label': 'operator', 'entity': '>'},\n",
       "   {'label': 'value', 'entity': '40 kg/m2'}]},\n",
       " {'text': 'Severe chronic obstructive pulmonary disease (COPD) or asthma.',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'chronic obstructive pulmonary disease (COPD)'},\n",
       "   {'label': 'condition', 'entity': 'asthma'}]},\n",
       " {'text': 'Neuromuscular disease that affects breathing.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Neuromuscular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': 'Patients must have a diagnosis of periodontitis and have at least 20 teeth.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'periodontitis'},\n",
       "   {'label': 'value', 'entity': 'at least 20'}]},\n",
       " {'text': 'Patients must have at least four teeth with probing depth ≥ 5 mm and clinical attachment loss ≥ 3 mm.',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'},\n",
       "   {'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Patients must be in good general health.', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': 'Patients who are pregnant or lactating.',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'pregnant'},\n",
       "   {'label': 'demographic', 'entity': 'lactating'}]},\n",
       " {'text': 'Patients who have a systemic disease that could affect the periodontium.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'systemic disease'}]},\n",
       " {'text': 'Patients who are taking medications that could affect the periodontium.',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'}]},\n",
       " {'text': 'Patients who have received periodontal treatment in the past 6 months.',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'periodontal treatment'},\n",
       "   {'label': 'value', 'entity': '6 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed HER2-positive metastatic breast cancer',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'HER2-positive metastatic breast cancer'}]},\n",
       " {'text': '- Progression of disease after prior trastuzumab-based therapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'trastuzumab-based therapy'}]},\n",
       " {'text': '- Measurable disease per RECIST 1.1 criteria',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- LVEF ≥50%',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'LVEF'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '50%'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with lapatinib',\n",
       "  'entities': [{'label': 'drug', 'entity': 'lapatinib'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of significant cardiac disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiac disease'}]},\n",
       " {'text': '- Uncontrolled hypertension',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uncontrolled hypertension'}]},\n",
       " {'text': '- Known hypersensitivity to lapatinib or its components',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'hypersensitivity to lapatinib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- At least 20 natural teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': '- Probing depth of 5-8 mm in at least 4 sites in different quadrants',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Probing depth'},\n",
       "   {'label': 'value', 'entity': '5-8 mm'}]},\n",
       " {'text': '- Clinical attachment level of ≥ 3 mm in the same sites',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Clinical attachment level'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': '- Bleeding on probing in the same sites',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Bleeding on probing'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Systemic diseases that may affect periodontal tissues',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic diseases'}]},\n",
       " {'text': '- Use of medications that may affect periodontal tissues',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'}]},\n",
       " {'text': '- Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': '- Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': '- Previous periodontal surgery',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'periodontal surgery'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- Patients with at least 20 teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'at least 20'}]},\n",
       " {'text': '- Patients with at least 4 sites with probing depth ≥ 5 mm and clinical attachment loss ≥ 3 mm',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'},\n",
       "   {'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients with systemic diseases that could affect periodontal tissues',\n",
       "  'entities': [{'label': 'condition', 'entity': 'systemic diseases'}]},\n",
       " {'text': '- Patients taking medications that could affect periodontal tissues',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'}]},\n",
       " {'text': '- Pregnant or breastfeeding women',\n",
       "  'entities': [{'label': 'demographic',\n",
       "    'entity': 'Pregnant or breastfeeding women'}]},\n",
       " {'text': '- Smokers',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smokers'}]},\n",
       " {'text': 'Inclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'periodontitis'}]},\n",
       " {'text': '- Patients with at least 20 teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'at least 20'}]},\n",
       " {'text': '- Patients with at least 4 teeth with a probing depth of 5 mm or more',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'value', 'entity': '5 mm or more'}]},\n",
       " {'text': '- Patients with a clinical attachment loss of 3 mm or more',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'value', 'entity': '3 mm or more'}]},\n",
       " {'text': 'Exclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients with any systemic disease that may affect the periodontium',\n",
       "  'entities': [{'label': 'condition', 'entity': 'systemic disease'}]},\n",
       " {'text': '- Patients who are taking any medication that may affect the periodontium',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medication'}]},\n",
       " {'text': '- Patients who are pregnant or lactating',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'pregnant or lactating'}]},\n",
       " {'text': '- Patients who are smokers',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'smokers'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically or cytologically confirmed diagnosis of adenocarcinoma of the colon or rectum',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'adenocarcinoma of the colon or rectum'}]},\n",
       " {'text': '- Metastatic disease not amenable to curative resection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Metastatic disease'},\n",
       "   {'label': 'procedure', 'entity': 'curative resection'}]},\n",
       " {'text': '- No prior chemotherapy for metastatic disease',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'chemotherapy'},\n",
       "   {'label': 'condition', 'entity': 'metastatic disease'}]},\n",
       " {'text': '- ECOG performance status 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (hematologic, renal, and hepatic)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior adjuvant chemotherapy with an oxaliplatin-containing regimen within the last 12 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'adjuvant chemotherapy'},\n",
       "   {'label': 'drug', 'entity': 'oxaliplatin-containing regimen'},\n",
       "   {'label': 'value', 'entity': '12 months'}]},\n",
       " {'text': '- Known central nervous system metastases',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'central nervous system metastases'}]},\n",
       " {'text': '- History of other malignancy within the last 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': '- Known hypersensitivity to any of the study drugs',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'study drugs'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- At least 20 teeth present',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': '- At least 4 sites with probing depth ≥ 5 mm and clinical attachment loss ≥ 3 mm',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'},\n",
       "   {'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Systemic diseases that may influence the course of periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic diseases'},\n",
       "   {'label': 'condition', 'entity': 'periodontitis'}]},\n",
       " {'text': '- Use of drugs known to influence the periodontium',\n",
       "  'entities': [{'label': 'drug', 'entity': 'drugs'}]},\n",
       " {'text': '- Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': '- Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': '- Periodontal treatment within the last 6 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'Periodontal treatment'},\n",
       "   {'label': 'value', 'entity': '6 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of pancreatic adenocarcinoma',\n",
       "  'entities': [{'label': 'condition', 'entity': 'pancreatic adenocarcinoma'}]},\n",
       " {'text': '- Locally advanced, unresectable, or metastatic disease',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Locally advanced, unresectable, or metastatic disease'}]},\n",
       " {'text': '- No prior systemic therapy for pancreatic cancer',\n",
       "  'entities': [{'label': 'drug', 'entity': 'systemic therapy'},\n",
       "   {'label': 'condition', 'entity': 'pancreatic cancer'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0 or 1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0 or 1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (bone marrow, liver, and kidney)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior radiation therapy to the pancreas',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'radiation therapy'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, with the exception of adequately treated non-melanoma skin cancer or cervical carcinoma in situ',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'cervical carcinoma in situ'}]},\n",
       " {'text': '- Known hypersensitivity to gemcitabine or nab-paclitaxel',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'gemcitabine'},\n",
       "   {'label': 'drug', 'entity': 'nab-paclitaxel'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced or metastatic non-small cell lung cancer (NSCLC)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'advanced or metastatic non-small cell lung cancer (NSCLC)'}]},\n",
       " {'text': '- Progression of disease after at least one prior line of systemic therapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'systemic therapy'}]},\n",
       " {'text': '- Presence of a sensitizing EGFR mutation (exon 19 deletion or L858R mutation)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'sensitizing EGFR mutation (exon 19 deletion or L858R mutation)'}]},\n",
       " {'text': '- Age ≥ 18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥ 18 years'}]},\n",
       " {'text': '- ECOG performance status of 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Life expectancy of at least 3 months',\n",
       "  'entities': [{'label': 'value', 'entity': 'at least 3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with an EGFR tyrosine kinase inhibitor (TKI)',\n",
       "  'entities': [{'label': 'drug',\n",
       "    'entity': 'EGFR tyrosine kinase inhibitor (TKI)'}]},\n",
       " {'text': '- Known T790M resistance mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'T790M resistance mutation'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically or cytologically confirmed diagnosis of metastatic colorectal cancer',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'metastatic colorectal cancer'}]},\n",
       " {'text': '- Progression of disease after standard therapies, including fluoropyrimidine, oxaliplatin, irinotecan, and a biologic agent (if appropriate)',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'fluoropyrimidine'},\n",
       "   {'label': 'drug', 'entity': 'oxaliplatin'},\n",
       "   {'label': 'drug', 'entity': 'irinotecan'},\n",
       "   {'label': 'drug', 'entity': 'biologic agent'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ and bone marrow function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with regorafenib',\n",
       "  'entities': [{'label': 'drug', 'entity': 'regorafenib'}]},\n",
       " {'text': '- Known BRAF V600E mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'BRAF V600E mutation'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Uncontrolled hypertension',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uncontrolled hypertension'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- At least 20 natural teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': '- Probing depth (PD) ≥ 5 mm in at least 4 sites',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Probing depth (PD)'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'}]},\n",
       " {'text': '- Clinical attachment level (CAL) ≥ 3 mm in the same sites',\n",
       "  'entities': [{'label': 'lab_test',\n",
       "    'entity': 'Clinical attachment level (CAL)'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Systemic diseases that could affect the periodontium',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic diseases'}]},\n",
       " {'text': '- Use of drugs that could affect the periodontium',\n",
       "  'entities': [{'label': 'drug', 'entity': 'drugs'}]},\n",
       " {'text': '- Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': '- Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': '- Periodontal surgery in the last 12 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'Periodontal surgery'},\n",
       "   {'label': 'value', 'entity': '12 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of metastatic melanoma',\n",
       "  'entities': [{'label': 'condition', 'entity': 'metastatic melanoma'}]},\n",
       " {'text': '- BRAF V600 mutation-positive',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'BRAF V600 mutation-positive'}]},\n",
       " {'text': '- No prior systemic therapy for metastatic disease',\n",
       "  'entities': [{'label': 'drug', 'entity': 'systemic therapy'},\n",
       "   {'label': 'condition', 'entity': 'metastatic disease'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0 or 1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0 or 1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Uveal melanoma',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uveal melanoma'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Known hypersensitivity to dabrafenib or trametinib',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'dabrafenib'},\n",
       "   {'label': 'drug', 'entity': 'trametinib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- At least 20 teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': '- At least 4 sites with probing depth ≥ 5mm and clinical attachment loss ≥ 3mm',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5mm'},\n",
       "   {'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3mm'}]},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Systemic diseases known to affect periodontal tissues',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic diseases'}]},\n",
       " {'text': '- Medications known to affect periodontal tissues',\n",
       "  'entities': [{'label': 'drug', 'entity': 'Medications'}]},\n",
       " {'text': '- Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': '- Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': '- Periodontal surgery in the previous 12 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'Periodontal surgery'},\n",
       "   {'label': 'value', 'entity': '12 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced or metastatic renal cell carcinoma (RCC) with a clear-cell component',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'advanced or metastatic renal cell carcinoma (RCC)'}]},\n",
       " {'text': '- No prior systemic therapy for advanced RCC',\n",
       "  'entities': [{'label': 'drug', 'entity': 'systemic therapy'},\n",
       "   {'label': 'condition', 'entity': 'advanced RCC'}]},\n",
       " {'text': '- Karnofsky Performance Status (KPS) ≥ 70%',\n",
       "  'entities': [{'label': 'lab_test',\n",
       "    'entity': 'Karnofsky Performance Status (KPS)'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '70%'}]},\n",
       " {'text': '- Age ≥ 18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥ 18 years'}]},\n",
       " {'text': '- Life expectancy ≥ 3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (hematologic, renal, and hepatic)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a VEGF-targeted therapy',\n",
       "  'entities': [{'label': 'drug', 'entity': 'VEGF-targeted therapy'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 3 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '3 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Uncontrolled hypertension',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uncontrolled hypertension'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of metastatic castration-resistant prostate cancer (mCRPC)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'metastatic castration-resistant prostate cancer (mCRPC)'}]},\n",
       " {'text': '- Progression of disease after treatment with at least one, and no more than two, previous chemotherapy regimens for mCRPC',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'procedure', 'entity': 'chemotherapy regimens'},\n",
       "   {'label': 'condition', 'entity': 'mCRPC'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (bone marrow, liver, and kidney)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with cabazitaxel',\n",
       "  'entities': [{'label': 'drug', 'entity': 'cabazitaxel'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Known hypersensitivity to cabazitaxel or other taxanes',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'cabazitaxel'},\n",
       "   {'label': 'drug', 'entity': 'taxanes'}]},\n",
       " {'text': 'Inclusion criteria:', 'entities': []},\n",
       " {'text': 'Patients with chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': 'At least 20 teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': 'Probing depth ≥ 5 mm in at least 4 teeth',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'}]},\n",
       " {'text': 'Clinical attachment loss ≥ 3 mm in at least 4 teeth',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'Clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Exclusion criteria:', 'entities': []},\n",
       " {'text': 'Systemic diseases that may affect the periodontium',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Systemic diseases'}]},\n",
       " {'text': 'Medications that may affect the periodontium',\n",
       "  'entities': [{'label': 'drug', 'entity': 'Medications'}]},\n",
       " {'text': 'Pregnancy or lactation',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Pregnancy'},\n",
       "   {'label': 'demographic', 'entity': 'lactation'}]},\n",
       " {'text': 'Smoking',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smoking'}]},\n",
       " {'text': 'Previous periodontal surgery',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'periodontal surgery'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of locally advanced or metastatic urothelial carcinoma',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'locally advanced or metastatic urothelial carcinoma'}]},\n",
       " {'text': '- Progression of disease during or after platinum-containing chemotherapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'platinum-containing chemotherapy'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ and bone marrow function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with an immune checkpoint inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'immune checkpoint inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of autoimmune disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'autoimmune disease'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': '- Known hypersensitivity to pembrolizumab or its excipients',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'pembrolizumab'}]},\n",
       " {'text': 'Inclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of chronic periodontitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'chronic periodontitis'}]},\n",
       " {'text': '- At least 20 teeth',\n",
       "  'entities': [{'label': 'value', 'entity': 'At least 20'}]},\n",
       " {'text': '- At least four sites with probing depth ≥ 5 mm and clinical attachment loss ≥ 3 mm',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'probing depth'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '5 mm'},\n",
       "   {'label': 'lab_test', 'entity': 'clinical attachment loss'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 mm'}]},\n",
       " {'text': 'Exclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients with systemic diseases that may affect periodontal tissues',\n",
       "  'entities': [{'label': 'condition', 'entity': 'systemic diseases'}]},\n",
       " {'text': '- Patients taking medications that may affect periodontal tissues',\n",
       "  'entities': [{'label': 'drug', 'entity': 'medications'}]},\n",
       " {'text': '- Pregnant or breastfeeding women',\n",
       "  'entities': [{'label': 'demographic',\n",
       "    'entity': 'Pregnant or breastfeeding women'}]},\n",
       " {'text': '- Smokers',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Smokers'}]},\n",
       " {'text': '- Patients who have had periodontal surgery in the past 12 months',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'periodontal surgery'},\n",
       "   {'label': 'value', 'entity': '12 months'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced or metastatic gastric or gastroesophageal junction adenocarcinoma',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'advanced or metastatic gastric or gastroesophageal junction adenocarcinoma'}]},\n",
       " {'text': '- Progression of disease after two or more prior lines of systemic therapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'systemic therapy'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with trifluridine/tipiracil',\n",
       "  'entities': [{'label': 'drug', 'entity': 'trifluridine/tipiracil'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Uncontrolled ascites requiring therapeutic paracentesis more than once every 4 weeks',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uncontrolled ascites'},\n",
       "   {'label': 'procedure', 'entity': 'therapeutic paracentesis'},\n",
       "   {'label': 'value', 'entity': 'more than once every 4 weeks'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of hepatocellular carcinoma (HCC)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'hepatocellular carcinoma (HCC)'}]},\n",
       " {'text': '- Unresectable or metastatic disease',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Unresectable or metastatic disease'}]},\n",
       " {'text': '- No prior systemic therapy for HCC',\n",
       "  'entities': [{'label': 'drug', 'entity': 'systemic therapy'},\n",
       "   {'label': 'condition', 'entity': 'HCC'}]},\n",
       " {'text': '- Child-Pugh class A liver function',\n",
       "  'entities': [{'label': 'lab_test',\n",
       "    'entity': 'Child-Pugh class A liver function'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ and bone marrow function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior liver transplantation',\n",
       "  'entities': [{'label': 'procedure', 'entity': 'liver transplantation'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of other malignancy within the past 5 years, with the exception of adequately treated non-melanoma skin cancer or cervical carcinoma in situ',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'cervical carcinoma in situ'}]},\n",
       " {'text': '- Known hypersensitivity to sorafenib or lenvatinib',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'sorafenib'},\n",
       "   {'label': 'drug', 'entity': 'lenvatinib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced or metastatic soft tissue sarcoma',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'advanced or metastatic soft tissue sarcoma'}]},\n",
       " {'text': '- Progression of disease after standard therapies, including an anthracycline-containing regimen',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'anthracycline-containing regimen'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (hematologic, renal, and hepatic)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with trabectedin',\n",
       "  'entities': [{'label': 'drug', 'entity': 'trabectedin'}]},\n",
       " {'text': '- Known central nervous system metastases',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'central nervous system metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced ovarian cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'advanced ovarian cancer'}]},\n",
       " {'text': '- Progression of disease more than 6 months after completion of platinum-based chemotherapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'value', 'entity': 'more than 6 months'},\n",
       "   {'label': 'drug', 'entity': 'platinum-based chemotherapy'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ and bone marrow function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a PARP inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'PARP inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Known hypersensitivity to olaparib or its components',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'olaparib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of small cell lung cancer (SCLC)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'small cell lung cancer (SCLC)'}]},\n",
       " {'text': '- Extensive-stage disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Extensive-stage disease'}]},\n",
       " {'text': '- Progression of disease after first-line platinum-based chemotherapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'platinum-based chemotherapy'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with lurbinectedin',\n",
       "  'entities': [{'label': 'drug', 'entity': 'lurbinectedin'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of advanced or metastatic cholangiocarcinoma',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'advanced or metastatic cholangiocarcinoma'}]},\n",
       " {'text': '- Progression of disease after at least one prior line of systemic therapy',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'systemic therapy'}]},\n",
       " {'text': '- Presence of an FGFR2 fusion or rearrangement',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'FGFR2 fusion or rearrangement'}]},\n",
       " {'text': '- Age ≥ 18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥ 18 years'}]},\n",
       " {'text': '- ECOG performance status of 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy of at least 3 months',\n",
       "  'entities': [{'label': 'value', 'entity': 'at least 3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with an FGFR inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'FGFR inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of retinal pigment epithelial detachment',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'retinal pigment epithelial detachment'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of acute myeloid leukemia (AML)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'acute myeloid leukemia (AML)'}]},\n",
       " {'text': '- Relapsed or refractory disease',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Relapsed or refractory disease'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Life expectancy ≥2 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '2 months'}]},\n",
       " {'text': '- Adequate organ function (renal and hepatic)', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Acute promyelocytic leukemia',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Acute promyelocytic leukemia'}]},\n",
       " {'text': '- Active central nervous system leukemia',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'central nervous system leukemia'}]},\n",
       " {'text': '- Prior allogeneic stem cell transplantation within 60 days',\n",
       "  'entities': [{'label': 'procedure',\n",
       "    'entity': 'allogeneic stem cell transplantation'},\n",
       "   {'label': 'value', 'entity': '60 days'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': '- Known hypersensitivity to gilteritinib or its components',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'gilteritinib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of diffuse large B-cell lymphoma (DLBCL)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'diffuse large B-cell lymphoma (DLBCL)'}]},\n",
       " {'text': '- Relapsed or refractory disease after at least two prior lines of therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Relapsed or refractory disease'}]},\n",
       " {'text': '- Not eligible for autologous stem cell transplantation',\n",
       "  'entities': [{'label': 'procedure',\n",
       "    'entity': 'autologous stem cell transplantation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Primary central nervous system lymphoma',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Primary central nervous system lymphoma'}]},\n",
       " {'text': '- Prior allogeneic stem cell transplantation',\n",
       "  'entities': [{'label': 'procedure',\n",
       "    'entity': 'allogeneic stem cell transplantation'}]},\n",
       " {'text': '- History of autoimmune disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'autoimmune disease'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': '- Known hypersensitivity to tafasitamab or lenalidomide',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'tafasitamab'},\n",
       "   {'label': 'drug', 'entity': 'lenalidomide'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of multiple myeloma',\n",
       "  'entities': [{'label': 'condition', 'entity': 'multiple myeloma'}]},\n",
       " {'text': '- Relapsed or refractory disease after at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Relapsed or refractory disease'},\n",
       "   {'label': 'drug', 'entity': 'proteasome inhibitor'},\n",
       "   {'label': 'drug', 'entity': 'immunomodulatory agent'},\n",
       "   {'label': 'drug', 'entity': 'anti-CD38 monoclonal antibody'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ function (hematologic, renal, and hepatic)',\n",
       "  'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a BCMA-targeted therapy',\n",
       "  'entities': [{'label': 'drug', 'entity': 'BCMA-targeted therapy'}]},\n",
       " {'text': '- Active plasma cell leukemia',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Active plasma cell leukemia'}]},\n",
       " {'text': '- Primary amyloidosis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Primary amyloidosis'}]},\n",
       " {'text': '- Active, uncontrolled infection',\n",
       "  'entities': [{'label': 'condition', 'entity': 'uncontrolled infection'}]},\n",
       " {'text': '- Known hypersensitivity to belantamab mafodotin or its components',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'belantamab mafodotin'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of triple-negative breast cancer (TNBC)',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'triple-negative breast cancer (TNBC)'}]},\n",
       " {'text': '- Locally advanced or metastatic disease',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Locally advanced or metastatic disease'}]},\n",
       " {'text': '- Progression of disease after at least two prior lines of systemic therapy for TNBC',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Progression of disease'},\n",
       "   {'label': 'drug', 'entity': 'systemic therapy'},\n",
       "   {'label': 'condition', 'entity': 'TNBC'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Life expectancy ≥3 months',\n",
       "  'entities': [{'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '3 months'}]},\n",
       " {'text': '- Adequate organ and bone marrow function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a Trop-2-directed antibody-drug conjugate',\n",
       "  'entities': [{'label': 'drug',\n",
       "    'entity': 'Trop-2-directed antibody-drug conjugate'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of another malignancy within the past 5 years, except for adequately treated non-melanoma skin cancer or in situ cervical cancer',\n",
       "  'entities': [{'label': 'condition', 'entity': 'malignancy'},\n",
       "   {'label': 'value', 'entity': '5 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'in situ cervical cancer'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients must have a pathologically confirmed diagnosis of a solid tumor that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective.',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Patients must have a tumor that harbors a NTRK1, NTRK2, or NTRK3 gene fusion.',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'tumor that harbors a NTRK1, NTRK2, or NTRK3 gene fusion'}]},\n",
       " {'text': '- Patients must have measurable disease.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'measurable disease'}]},\n",
       " {'text': '- Patients must be ≥ 12 years of age.',\n",
       "  'entities': [{'label': 'demographic', 'entity': '≥ 12 years of age'}]},\n",
       " {'text': '- Patients must have an ECOG performance status of 0-2.',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Patients must have adequate organ function.', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients who have had prior treatment with a TRK inhibitor.',\n",
       "  'entities': [{'label': 'drug', 'entity': 'TRK inhibitor'}]},\n",
       " {'text': '- Patients with a known hypersensitivity to larotrectinib or its excipients.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'larotrectinib'}]},\n",
       " {'text': '- Patients with active brain metastases.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'active brain metastases'}]},\n",
       " {'text': '- Patients with a history of another primary malignancy within the past 3 years, with the exception of adequately treated non-melanoma skin cancer or cervical cancer in situ.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'primary malignancy'},\n",
       "   {'label': 'value', 'entity': '3 years'},\n",
       "   {'label': 'condition', 'entity': 'non-melanoma skin cancer'},\n",
       "   {'label': 'condition', 'entity': 'cervical cancer in situ'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that has progressed on or is intolerant to standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that has progressed on or is intolerant to standard therapy'}]},\n",
       " {'text': '- Presence of a RET gene fusion',\n",
       "  'entities': [{'label': 'condition', 'entity': 'RET gene fusion'}]},\n",
       " {'text': '- Age ≥12 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥12 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a selective RET inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'selective RET inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients with a histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable and has progressed following prior treatment and for which no satisfactory alternative therapy exists.',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable and has progressed following prior treatment'}]},\n",
       " {'text': '- Patients must have a tumor with a high tumor mutational burden (TMB-H) [≥10 mutations/megabase (mut/Mb)] as determined by the FoundationOne CDx assay.',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'tumor with a high tumor mutational burden (TMB-H)'},\n",
       "   {'label': 'operator', 'entity': '≥'},\n",
       "   {'label': 'value', 'entity': '10 mutations/megabase (mut/Mb)'},\n",
       "   {'label': 'lab_test', 'entity': 'FoundationOne CDx assay'}]},\n",
       " {'text': '- Patients must have measurable disease as per RECIST v1.1.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'measurable disease'}]},\n",
       " {'text': '- Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.',\n",
       "  'entities': [{'label': 'lab_test',\n",
       "    'entity': 'Eastern Cooperative Oncology Group (ECOG) performance status'},\n",
       "   {'label': 'value', 'entity': '0 or 1'}]},\n",
       " {'text': '- Patients must have a life expectancy of at least 3 months.',\n",
       "  'entities': [{'label': 'value', 'entity': 'at least 3 months'}]},\n",
       " {'text': '- Patients must have adequate organ function.', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Patients who have had prior treatment with an anti-PD-1, anti-PD-L1, or anti-CTLA-4 antibody.',\n",
       "  'entities': [{'label': 'drug',\n",
       "    'entity': 'anti-PD-1, anti-PD-L1, or anti-CTLA-4 antibody'}]},\n",
       " {'text': '- Patients with a known hypersensitivity to pembrolizumab or any of its excipients.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'pembrolizumab'}]},\n",
       " {'text': '- Patients with an active autoimmune disease that has required systemic treatment in the past 2 years.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'autoimmune disease'},\n",
       "   {'label': 'drug', 'entity': 'systemic treatment'},\n",
       "   {'label': 'value', 'entity': '2 years'}]},\n",
       " {'text': '- Patients with a medical condition that requires systemic corticosteroids or other immunosuppressive medications.',\n",
       "  'entities': [{'label': 'condition', 'entity': 'medical condition'},\n",
       "   {'label': 'drug', 'entity': 'systemic corticosteroids'},\n",
       "   {'label': 'drug', 'entity': 'immunosuppressive medications'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Progression on or after prior standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Progression on or after prior standard therapy'}]},\n",
       " {'text': '- Presence of a MET exon 14 skipping mutation',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'MET exon 14 skipping mutation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a MET inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'MET inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Progression on or after prior standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Progression on or after prior standard therapy'}]},\n",
       " {'text': '- Presence of a KRAS G12C mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'KRAS G12C mutation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a KRAS G12C inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'KRAS G12C inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients with a diagnosis of a solid tumor that is metastatic or unresectable and for which standard therapy is not available or is no longer effective',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Patients must have a tumor that harbors a BRAF V600E mutation',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'tumor that harbors a BRAF V600E mutation'}]},\n",
       " {'text': '- Patients must have measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'measurable disease'}]},\n",
       " {'text': '- Patients must be at least 18 years old',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'at least 18 years old'}]},\n",
       " {'text': '- Patients must have an ECOG performance status of 0 or 1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0 or 1'}]},\n",
       " {'text': '- Patients must have adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion criteria:', 'entities': []},\n",
       " {'text': '- Patients who have received prior treatment with a BRAF or MEK inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'BRAF or MEK inhibitor'}]},\n",
       " {'text': '- Patients with a history of retinal vein occlusion',\n",
       "  'entities': [{'label': 'condition', 'entity': 'retinal vein occlusion'}]},\n",
       " {'text': '- Patients with a history of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Patients with a known hypersensitivity to dabrafenib or trametinib',\n",
       "  'entities': [{'label': 'condition', 'entity': 'hypersensitivity'},\n",
       "   {'label': 'drug', 'entity': 'dabrafenib'},\n",
       "   {'label': 'drug', 'entity': 'trametinib'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable and for which there is no available standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Presence of an IDH1 or IDH2 mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'IDH1 or IDH2 mutation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with an IDH1 or IDH2 inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'IDH1 or IDH2 inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of retinal pigment epithelial detachment',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'retinal pigment epithelial detachment'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Progression on or after prior standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Progression on or after prior standard therapy'}]},\n",
       " {'text': '- Presence of an ALK rearrangement',\n",
       "  'entities': [{'label': 'condition', 'entity': 'ALK rearrangement'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-2',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-2'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with an ALK inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'ALK inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable and for which there is no available standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Presence of a ROS1 rearrangement',\n",
       "  'entities': [{'label': 'condition', 'entity': 'ROS1 rearrangement'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a ROS1 inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'ROS1 inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of interstitial lung disease or pneumonitis',\n",
       "  'entities': [{'label': 'condition', 'entity': 'interstitial lung disease'},\n",
       "   {'label': 'condition', 'entity': 'pneumonitis'}]},\n",
       " {'text': '- Significant cardiovascular disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'cardiovascular disease'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Progression on or after prior standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Progression on or after prior standard therapy'}]},\n",
       " {'text': '- Presence of a PIK3CA mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'PIK3CA mutation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a PI3K inhibitor',\n",
       "  'entities': [{'label': 'drug', 'entity': 'PI3K inhibitor'}]},\n",
       " {'text': '- Active brain metastases',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Active brain metastases'}]},\n",
       " {'text': '- History of severe cutaneous reactions to alpelisib',\n",
       "  'entities': [{'label': 'condition', 'entity': 'severe cutaneous reactions'},\n",
       "   {'label': 'drug', 'entity': 'alpelisib'}]},\n",
       " {'text': '- Uncontrolled diabetes',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Uncontrolled diabetes'}]},\n",
       " {'text': 'Inclusion Criteria:', 'entities': []},\n",
       " {'text': '- Histologically confirmed diagnosis of a solid tumor that is metastatic or unresectable',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'solid tumor that is metastatic or unresectable'}]},\n",
       " {'text': '- Progression on or after prior standard therapy',\n",
       "  'entities': [{'label': 'condition',\n",
       "    'entity': 'Progression on or after prior standard therapy'}]},\n",
       " {'text': '- Presence of a BRCA1 or BRCA2 mutation',\n",
       "  'entities': [{'label': 'condition', 'entity': 'BRCA1 or BRCA2 mutation'}]},\n",
       " {'text': '- Age ≥18 years',\n",
       "  'entities': [{'label': 'demographic', 'entity': 'Age ≥18 years'}]},\n",
       " {'text': '- ECOG performance status 0-1',\n",
       "  'entities': [{'label': 'lab_test', 'entity': 'ECOG performance status'},\n",
       "   {'label': 'value', 'entity': '0-1'}]},\n",
       " {'text': '- Measurable disease',\n",
       "  'entities': [{'label': 'condition', 'entity': 'Measurable disease'}]},\n",
       " {'text': '- Adequate organ function', 'entities': []},\n",
       " {'text': 'Exclusion Criteria:', 'entities': []},\n",
       " {'text': '- Prior treatment with a PAR',\n",
       "  'entities': [{'label': 'drug', 'entity': 'PAR'}]}]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "raw_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "efcae9e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 543 annotated examples from '../data\\processed\\all.json'.\n"
     ]
    }
   ],
   "source": [
    "dataset = Dataset.from_dict({\n",
    "    \"text\": [item[\"text\"] for item in raw_data],\n",
    "    \"ner_tags_spans\": [item.get(\"label\", []) for item in raw_data]\n",
    "})\n",
    "print(f\"Loaded {len(dataset)} annotated examples from '{ANNOTATION_FILE}'.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "53ec788c",
   "metadata": {},
   "outputs": [],
   "source": [
    "tag_names = ['O'] + [f'{prefix}-{tag}' for tag in LABELS for prefix in ['B', 'I']]\n",
    "tag2id = {tag: i for i, tag in enumerate(tag_names)}\n",
    "id2tag = {i: tag for tag, i in tag2id.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "ab658864",
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = AutoTokenizer.from_pretrained(MODEL_CHECKPOINT)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fe6c5f0c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def tokenize_and_align_labels(examples):\n",
    "    tokenized_inputs = tokenizer(examples[\"text\"], truncation=True, is_split_into_words=False)\n",
    "    all_labels = []\n",
    "    for i, spans in enumerate(examples[\"ner_tags_spans\"]):\n",
    "        word_ids = tokenized_inputs.word_ids(batch_index=i)\n",
    "        label_ids = {} \n",
    "        for start, end, label in spans:\n",
    "            for token_idx in range(len(tokenized_inputs.input_ids[i])):\n",
    "                char_start, char_end = tokenized_inputs.token_to_chars(i, token_idx)\n",
    "                if char_start is None: continue\n",
    "                \n",
    "                if max(start, char_start) < min(end, char_end):\n",
    "                    word_id = word_ids[token_idx]\n",
    "                    if word_id is not None:\n",
    "                        prefix = \"B\"\n",
    "                        if token_idx > 0 and word_ids[token_idx-1] == word_id:\n",
    "                            if label_ids.get(word_id) is not None:\n",
    "                                prefix = \"I\"\n",
    "                        \n",
    "                        tag = f\"{prefix}-{label}\"\n",
    "                        if tag in tag2id:\n",
    "                            label_ids[word_id] = tag2id[tag]\n",
    "                        else:\n",
    "                            print(f\"Warning: Label '{label}' not found in schema. Skipping.\")\n",
    "        \n",
    "        final_labels = []\n",
    "        previous_word_idx = None\n",
    "        for word_idx in word_ids:\n",
    "            if word_idx is None:\n",
    "                final_labels.append(-100)\n",
    "            else:\n",
    "                label_id = label_ids.get(word_idx)\n",
    "                if label_id is not None:\n",
    "\n",
    "                    if word_idx == previous_word_idx:\n",
    "                        tag = tag_names[label_id].replace(\"B-\", \"I-\")\n",
    "                        final_labels.append(tag2id.get(tag, label_id))\n",
    "                    else:\n",
    "                        final_labels.append(label_id)\n",
    "                else:\n",
    "                    final_labels.append(tag2id['O'])\n",
    "            previous_word_idx = word_idx\n",
    "        all_labels.append(final_labels)\n",
    "\n",
    "    tokenized_inputs[\"labels\"] = all_labels\n",
    "    return tokenized_inputs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "83bd8fcb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Tokenizing text and aligning labels with the IOB2 scheme...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map:   0%|          | 0/543 [00:00<?, ? examples/s]Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n",
      "Map: 100%|██████████| 543/543 [00:00<00:00, 20529.92 examples/s]\n"
     ]
    }
   ],
   "source": [
    "print(\"\\nTokenizing text and aligning labels with the IOB2 scheme...\")\n",
    "tokenized_dataset = dataset.map(\n",
    "    tokenize_and_align_labels,\n",
    "    batched=True,\n",
    "    remove_columns=dataset.column_names\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "772057cb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Dataset({\n",
       "    features: ['input_ids', 'token_type_ids', 'attention_mask', 'labels'],\n",
       "    num_rows: 543\n",
       "})"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokenized_dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "f1d8d8a3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Splitting data into a training set (90%) and an evaluation set (10%):\n",
      "DatasetDict({\n",
      "    train: Dataset({\n",
      "        features: ['input_ids', 'token_type_ids', 'attention_mask', 'labels'],\n",
      "        num_rows: 488\n",
      "    })\n",
      "    test: Dataset({\n",
      "        features: ['input_ids', 'token_type_ids', 'attention_mask', 'labels'],\n",
      "        num_rows: 55\n",
      "    })\n",
      "})\n"
     ]
    }
   ],
   "source": [
    "final_dataset = tokenized_dataset.train_test_split(test_size=0.1, seed=42)\n",
    "print(\"\\nSplitting data into a training set (90%) and an evaluation set (10%):\")\n",
    "print(final_dataset)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "a74a4bb3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Saving the dataset (1/1 shards): 100%|██████████| 488/488 [00:00<00:00, 37081.42 examples/s]\n",
      "Saving the dataset (1/1 shards): 100%|██████████| 55/55 [00:00<00:00, 4231.00 examples/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Processed dataset saved to '../data\\ner_dataset'. Ready for training.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "final_dataset.save_to_disk(OUTPUT_DATASET_FOLDER)\n",
    "print(f\"\\nProcessed dataset saved to '{OUTPUT_DATASET_FOLDER}'. Ready for training.\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
